Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients

Background: For stage I–II colon cancer a significant number (5–25%) of patients has recurrent disease within 5 years. There is need to identify these high-risk patients as they might benefit from additional treatment. Stroma-tissue surrounding the cancer cells plays an important role in the tumor b...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesker, Wilma E., Liefers, Gerrit-Jan, Junggeburt, Jan M. C., van Pelt, Gabi W., Alberici, Paola, Kuppen, Peter J. K., Miranda, Noel F., van Leeuwen, Karin A. M., Morreau, Hans, Szuhai, Karoly, Tollenaar, Rob A. E. M., Tanke, Hans J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2009
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618830/
https://www.ncbi.nlm.nih.gov/pubmed/19478385
http://dx.doi.org/10.3233/CLO-2009-0478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618830/
https://www.ncbi.nlm.nih.gov/pubmed/19478385
http://dx.doi.org/10.3233/CLO-2009-0478

Ejemplares similares